Post by
TexasTea20 on Apr 06, 2021 5:43pm
Just tossing it out there...
Any thoughts on the possibiltiy that Merck, after having some sort of a gerneral agreement/understanding with IMV in place subject to PII DLBCL trial design approval by the FDA and further cost clarity may just say, Fug it... Lets buy these guy now while they are as cheap as borscht? Its what one of my pals thinks is a possibility. There are, theoretically at least, four Survivin indications that could be valued for this pupose... $1B -$1.5B per.
My apologies. Just trying to keep myself interested in this under-performer by making stuff up.
Comment by
Jthom376 on Apr 06, 2021 5:49pm
Texas.... I think you're right and I think Merck... who has no COVID vaccine, it going to pick up IMVs play! LOL
Comment by
TexasTea20 on Apr 06, 2021 5:55pm
Jthom, I like it...except IMV doesnt have a COVID vaccine either.... but I guess thats your point. Ok back to work.